Internal Medicine, Hematology & Oncology · Kingston, PA
NPI
1053337295
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
382 Pierce St
Kingston, PA, 18704
Phone (570) 288-7231
Groups this clinician bills Medicare through
Medicare paid, 2024
$5.5M
427,524 services
Medicare patients, 2024
1,004
Average age 76
Drug cost, 2024
$6.6M
1,338 prescriptions
Company payments, 2025
$955
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bruce H Saidman was code J1439 (injection, ferric carboxymaltose, 1 mg), 203,250 times for 106 patients. In total Bruce H Saidman billed 427,524 services in 144 codes, and Medicare paid $5.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 203,250 | 106 | $0.87 | $176K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 29,000 | 23 | $43.67 | $1.3M |
| J0897 Injection, denosumab, 1 mg | Office | 17,400 | 83 | $20.45 | $356K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 13,500 | 13 | $0.06 | $775 |
| J9267 Injection, paclitaxel, 1 mg | Office | 8,670 | 11 | $0.08 | $693 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 4,944 | 64 | $0.09 | $434 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 3,830 | 58 | $0.70 | $2,688 |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 2,848 | 16 | $3.54 | $10K |
| 85025 Blood Count | Office | 2,677 | 670 | $7.56 | $20K |
| 99213 Office E&M - Established | Office | 1,709 | 663 | $67.19 | $115K |
| 80053 Clinical Chemistry | Office | 1,383 | 382 | $10.26 | $14K |
| 82248 Clinical Chemistry | Office | 977 | 236 | $4.87 | $4,755 |
| 83615 Clinical Chemistry | Office | 869 | 266 | $5.87 | $5,099 |
| 36415 Venipuncture Blood Collection | Office | 827 | 383 | $8.62 | $7,128 |
| 99211 Office E&M - Established | Office | 788 | 253 | $17.06 | $13K |
By year: 2022 $6.1M for 442,992 services; 2023 $6.2M for 531,518 services; 2024 $5.5M for 427,524 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,677 | 670 | $7.56 | $20K |
| 80053 Clinical Chemistry | 1,383 | 382 | $10.26 | $14K |
| 82248 Clinical Chemistry | 977 | 236 | $4.87 | $4,755 |
| 83615 Clinical Chemistry | 869 | 266 | $5.87 | $5,099 |
| 36415 Venipuncture Blood Collection | 827 | 383 | $8.62 | $7,128 |
| 83550 Clinical Chemistry | 380 | 200 | $8.55 | $3,248 |
| 83540 Clinical Chemistry | 377 | 198 | $6.32 | $2,384 |
| 83735 Clinical Chemistry | 119 | 42 | $6.57 | $782 |
| 80048 Clinical Chemistry | 52 | 39 | $8.29 | $431 |
| 84550 Clinical Chemistry | 45 | 20 | $4.43 | $199 |
Medicare prescription drug claims, 2024
In 2024, the drug Bruce H Saidman prescribed most often to Medicare patients was Letrozole, with 299 prescriptions and refills. In total Bruce H Saidman wrote 1,338 Medicare prescriptions that cost $6.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 299 | 552 | 67 | $6,142 |
| Hydroxyurea Generic | 72 | 98 | 12 | $1,339 |
| Exemestane Generic | 59 | 107 | 13 | $6,497 |
| Tamoxifen Citrate Generic | 56 | 94 | Under 11 | $1,641 |
| Imatinib Mesylate Generic | 52 | 60 | Under 11 | $120K |
| Anastrozole Generic | 46 | 104 | 11 | $1,236 |
| Jakafi Ruxolitinib Phosphate | 42 | 42 | Under 11 | $777K |
| Brukinsa Zanubrutinib | 41 | 41 | Under 11 | $626K |
| Calquence Acalabrutinib Maleate | 36 | 36 | Under 11 | $533K |
| Prednisone Generic | 31 | 41 | 18 | $213 |
| Nubeqa Darolutamide | 29 | 29 | Under 11 | $411K |
| Lenalidomide Generic | 26 | 26 | Under 11 | $381K |
| Dexamethasone Generic | 20 | 20 | Under 11 | $148 |
| Kisqali Ribociclib Succinate | 20 | 20 | Under 11 | $291K |
| Pomalyst Pomalidomide | 20 | 20 | Under 11 | $453K |
Brand drugs: 415 claims; generic drugs: 923 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bruce H Saidman $955 ($955 in general payments such as food, travel and fees) from 19 companies. The largest payer was Pfizer Inc. with $173.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 11 | $173 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $136 |
| Abbvie Inc. ABBV | 4 | $79.54 |
| Merck Sharp & Dohme LLC MRK | 4 | $71.62 |
| GlaxoSmithKline, LLC. GSK | 3 | $68.88 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $60.14 |
| Genentech USA, Inc. ROG.SW | 1 | $53.45 |
| Celgene Corporation BMY | 3 | $50.35 |
| Array Biopharma Inc PFE | 2 | $47.72 |
| Genzyme Corporation SNY | 2 | $34.58 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.